Skip to main content

Table 3 Paired sample t test mean difference of the DCE parameters between pre- vs. intra-treatment study and between intra- vs. post-treatment study

From: Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a comparative study of pharmacokinetic models and correlation with mRECIST criteria

Parameters

Intra- vs. pre-treatment study, mean +/-SD (p-value)

Post- vs. intra-treatment study, mean +/− SD (p-value)

ET-Ktrans max

−0.001 +/− 0.06 (>.05)

0.002 +/− 0.3 (>.05)

AATH-Ktrans max

−0.02 +/− 0.06 (>.05)

−0.06 +/− 0.2 (> 0.05)

ET-kep max

−0.1 +/− 0.5 (>.05)

0.05 +/− 0.8 (>.05)

AATH-kep max

0.1 +/− 1.6 (>.05)

- 0.2 +/− 1.7 (>.05)

ET-AUC max

− 5062 +/−  26,775 (>.05)

− 9783 +/−  29,591 (>.05)

AATH-AUC max

− 3310 +/−  27,804 (>.05)

− 9606 +/− 25,440 (>.05)

ET-vp max

- 0.01 +/−  0.3 (>.05)

− 0.04 +/−  0.3 (>.05)

AATH-vp max

0

0

ET-ve med

0.009 +/−  0.2 (>.05)

−0.05 +/− 0.3 (>.05)

AATH-ve med

0.07 +/−  0.2 (>.05)

− 0.09 +/−  0.4 (> 0.05)

TC-max

6 +/−  62. (>.05)

−4 +/− 68 (>.05)

E-max

0.009 +/−  0.02 (>.05)

− 0.005 +/−  0.02 (>.05)

F-max

−10 +/− 34 (.05)

40 +/−  168 (>.05)

  1. Note: Ktrans (1/min), kep (1/min), AUC (mM), ve (ml/100 ml), vp (ml/100 ml), TC (min), F (ml/min/100 ml), E (%)